These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23554895)

  • 1. Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.
    Song Y; Rubio A; Jayaswal RK; Silverman JA; Wilkinson BJ
    PLoS One; 2013; 8(3):e58469. PubMed ID: 23554895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.
    Hübscher J; Jansen A; Kotte O; Schäfer J; Majcherczyk PA; Harris LG; Bierbaum G; Heinemann M; Berger-Bächi B
    BMC Genomics; 2007 Sep; 8():307. PubMed ID: 17784943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
    Cafiso V; Bertuccio T; Spina D; Purrello S; Campanile F; Di Pietro C; Purrello M; Stefani S
    PLoS One; 2012; 7(1):e29573. PubMed ID: 22253738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
    Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
    mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
    Cui L; Isii T; Fukuda M; Ochiai T; Neoh HM; Camargo IL; Watanabe Y; Shoji M; Hishinuma T; Hiramatsu K
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5222-33. PubMed ID: 20837752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.
    Fischer A; Yang SJ; Bayer AS; Vaezzadeh AR; Herzig S; Stenz L; Girard M; Sakoulas G; Scherl A; Yeaman MR; Proctor RA; Schrenzel J; François P
    J Antimicrob Chemother; 2011 Aug; 66(8):1696-711. PubMed ID: 21622973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
    Passalacqua KD; Satola SW; Crispell EK; Read TD
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5212-23. PubMed ID: 22850507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.
    Bertsche U; Weidenmaier C; Kuehner D; Yang SJ; Baur S; Wanner S; Francois P; Schrenzel J; Yeaman MR; Bayer AS
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3922-8. PubMed ID: 21606222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
    Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
    Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
    PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
    Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
    J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
    Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus.
    Peleg AY; Miyakis S; Ward DV; Earl AM; Rubio A; Cameron DR; Pillai S; Moellering RC; Eliopoulos GM
    PLoS One; 2012; 7(1):e28316. PubMed ID: 22238576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon.
    Mechler L; Bonetti EJ; Reichert S; Flötenmeyer M; Schrenzel J; Bertram R; François P; Götz F
    Antimicrob Agents Chemother; 2016 May; 60(5):2684-91. PubMed ID: 26883712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant.
    Song Y; Lunde CS; Benton BM; Wilkinson BJ
    Microb Drug Resist; 2013 Aug; 19(4):247-55. PubMed ID: 23551248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
    Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.
    Yang SJ; Kreiswirth BN; Sakoulas G; Yeaman MR; Xiong YQ; Sawa A; Bayer AS
    J Infect Dis; 2009 Dec; 200(12):1916-20. PubMed ID: 19919306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
    Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
    PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
    Jiang JH; Dexter C; Cameron DR; Monk IR; Baines SL; Abbott IJ; Spelman DW; Kostoulias X; Nethercott C; Howden BP; Peleg AY
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.